YWHAQ and Parkinson disease: The 14-3-3 proteins can also reduce cell-to-cell transfer and propagation of α-synuclein, a key pathogenic protein in Parkinson's disease (Wang et al., 2018), and can exert a neuroprotective effect against α-synuclein toxicity in vivo (Underwood et al., 2021).